Quantum-Si Inc (NAS:QSI)

$ 3.6 1.43 (66.51%) Market Cap: 513.77 Mil Enterprise Value: 124.31 Mil PE Ratio: 0 PB Ratio: 2.44 GF Score: 36/100

Q3 2024 Quantum-Si Inc Earnings Call Transcript
Nov 12, 2024

$0.7753 (-22.43%)

Earnings
Q2 2024 Quantum-Si Inc Earnings Call Transcript
Aug 07, 2024

$0.82 (-5.91%)

Earnings
Q4 2023 Quantum-Si Inc Earnings Call Transcript
Feb 29, 2024

$1.67 (-4.02%)

Earnings
Q3 2023 Quantum-Si Inc Earnings Call Transcript
Nov 09, 2023

$1.33 (+7.26%)

Earnings
Quantum-Si Inc at Canaccord Genuity Growth Conference Transcript
Aug 10, 2023
Q2 2023 Quantum-Si Inc Earnings Call Transcript
Aug 07, 2023

$2.3 (-32.15%)

Earnings
Quantum-Si Inc at Jefferies Healthcare Conference Transcript
Jun 08, 2023
Q1 2023 Quantum-Si Inc Earnings Call Transcript
May 11, 2023

$1.54 (-5.52%)

Earnings
Quantum-Si Inc Annual Shareholders Meeting Transcript
May 11, 2023
Quantum-Si Inc at Cowen Health Care Conference Transcript
Mar 07, 2023
Q4 2022 Quantum-Si Inc Earnings Call Transcript
Mar 06, 2023

$1.88 (-12.96%)

Earnings
Quantum-Si Inc at JPMorgan Healthcare Conference Transcript
Jan 12, 2023
Quantum-Si Inc at Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum Transcript
Nov 17, 2022
Q3 2022 Quantum-Si Inc Earnings Call Transcript
Nov 07, 2022

$2.53 (+1.20%)

Earnings
Quantum-Si Inc at Morgan Stanley Global Healthcare Conference Transcript
Sep 14, 2022
Quantum-Si Inc at UBS Genomics 2.0 and MedTech Innovations Summit Transcript
Aug 11, 2022
Quantum-Si Inc at Canaccord Genuity Growth Conference Transcript
Aug 10, 2022
Q2 2022 Quantum-Si Inc Earnings Call Transcript
Aug 08, 2022

$3.96 (+3.66%)

Earnings
Quantum-Si Inc at Jefferies Healthcare Conference Transcript
Jun 10, 2022
Quantum-Si Inc at UBS Global Healthcare Conference Transcript
May 23, 2022
Q1 2022 Quantum-Si Inc Earnings Call Transcript
May 09, 2022

$3.49 (-11.87%)

Earnings
Q4 2021 Quantum-Si Inc Earnings Call Transcript
Feb 28, 2022

Earnings

Quantum-Si Inc at Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum Transcript

Nov 17, 2022 / 08:30PM GMT

Release Date Price: $3.02 (+0.33%)

Transcript

Kyle Mikson

Canaccord Genuity - Analyst

Welcome, everyone, to the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum. I'm Kyle Mikson, I cover life science tools and diagnostics for Canaccord. And we're really pleased to have Quantum-Si here with us today for a fireside chat.

The company is developing and is soon to be launching a next-generation protein sequencing platform, first of its kind. And with us from QSI, we have Jeff Hawkins, new CEO, and then Patrick Schneider, the President and Chief Operating Officer. So, thanks guys for joining us today. Great to have you.

Questions & Answers

Kyle Mikson

Canaccord Genuity - Analyst

Awesome. So, Jeff, you officially started in your new role with the company on October 10. Maybe walk through your background, what attracted you to QSI, and what's your, I guess, path forward goals now going forward?

Jeff Hawkins

Quantum-Si Inc. - CEO

Yes. Sure. So yeah, we're about, I guess, six weeks into the job. I've spent the last

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.